Black Tie International Magazine
Home
 
Select your preferred language
 
 
Celebrity Philanthropy News
 
Society News
 
Save the Date 2022
 
Editor-in-Chief
Joyce Brooks
 
Publisher
Gerard Mc Keon
 
Black Tie  TV
 
Nightlife With
Rose Billings
 
Now Trending
with Alison Minton
 
On the Town
Audrey Reuben
 
Dr. Ma. Xiaoqiu
DYF Entertainment
 
Impact Investment
 
Featured Foundations
 
Advertising
 
Co-Hosting Events
 
Listing Non-Profit Events
 
 
Share this Page
   
 
Black Tie China
 
Black Tie France
 
Black Tie Israel
 
Black Tie Philippines
 
New York Society
 
Palm Beach Society
 
International Society
 
Hampton Society
 
Las Vegas Society
 
West Coast Society
 
U.S. Society
 
Philanthropy  Giving
 
Entrepreneurial & Philanthropy Awards
 
Event Resource Directory
 
Promote your Services
 
Event Talent Directory
 
Feature Your Talent
 
Antiques
Art
Beauty
Blockchain
Cars
Couture Fashion
Crowdfunding
Fine Wines
 Health & Wellness
Interior Design
Investigative Services
Jewelry
Kids on Location
Legal Services
Luxury Yachts
Pet Services
Private Air
 Real Estate
Recommended Reading
Restaurant Reviews
Single Friendly Events
Social Announcements
Sustainable Investment
Technology
Theater/Arts
Travel
Wealth Management
 
 
Add your e-mail
 Friends
of Black Tie

 
 
Black Tie Classic
George Clooney
Princess Diana
Back Issues
More Back Issues
 
 
 
 
 
 

 

web
analytics
 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Society News  Pages 1  2  3
 Forward this page to your friends

 
Black Tie International:
 Global Health Impact Forum
Photos by:  GMK/Blacktiemagazine.com
 

Alex Charlton, President of Corporate Relations, Cavendish Global,

Alex Charlton, President of Corporate Relations, Cavendish Global,
Dr. Jonathan Sackier, President & Chief Medical Officer, Cavendish Global, 
Michael Moffat, Director of Family Office Relations, Cavendish Global

Amir Dossal, Chairman, Global Partnerships Forum

Cavendish
Global Health Impact Forum

Global Health Impact Forum: A unique platform for pro-social family offices and foundations in support of the goals and
objectives of the United Nations System. A discrete, peer-to-peer knowledge expansion and relationship building environment
focused on health for a global network of over 150 leading family offices and foundations. A world-class forum for organizations actively
seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing

Principal objectives of the Forum:

1. Champion and Share:   
Provide a peer-to-peer setting for family offices and their foundations to
champion and share information on sustainable philanthropy,
grant-giving and impact investing projects which they are passionate about with other family offices from around the world

2. Access Knowledge and Insight:   Help family offices and foundations identify the best scientific minds, accomplished healthcare delivery professionals, philanthropic organizations, health-policy
experts and compelling private sector companies with the potential for transformational impact on disease prevention, diagnosis and treatment

3. Partners for Action: Action-driven platform to establish new partnerships and alliances for improved health outcomes and access; utilizing information and communication technologies (ICTs)
as a key enabler

Program highlights include:
Over 150 Family Investment Offices and Foundations represented from North America, Europe, Asia, Africa and Latin America!

Over 50 accomplished healthcare delivery professionals, health-policy experts, and philanthropic organizations reveal specific
programs driving meaningful improvements in health, health access and medical outcomes on a regional or national basis!

Over 50 groundbreaking discoveries and innovations by scientists and private-sector CEO’s revealing groundbreaking discoveries
and technology with the potential for transformational impact on disease prevention, diagnosis, treatment and medical outcomes!

 Senior partners from top-30 private equity firms and pro-social funds participating in panel discussions (including Aisling
Capital, Arsenal Capital Partners, Bridges Ventures, CityLight Capital,
 Easton Capital, Domain Ventures, and SV Life Sciences)
 

Dr. Roland Rich, Executive Director, United Nations Office for Partnerships,

Dr. Roland Rich, Executive Director, United Nations Office for Partnerships,
Amir Dossal, Chairman, Global Partnerships Forum
Saralyn Mark, MD,
Ambassador Gyan Chandra Acharya, High Representative for the Least Developed Countries, Landlocked Developing Countries and Small Island Developing States
 Mr. Gary Fowlie, Head, ITU Liaison Office to the UN

Mr. Peter Samuelson, Chairman, Co-Founder and President, The Starlight Children’s Foundation,Ms. Kay Koplovitz, Co-founder Springboard Enterprises and Founder USA Network,Mr. Josh Cohen, Co-Founder, Managing Director, City Light Capita, Mr. Gregory C. Simon, Chief Executive Officer Poliwogg,Mr. Brian Trelstad, Managing Director, Bridges Ventures,Ms. Liesel Pritzker Simmons, Social entrepreneur, co-founder,Mr. Peter Samuelson, Chairman, Co-Founder and President, The Starlight Children’s Foundation,Ms. Kay Koplovitz, Co-founder Springboard Enterprises and Founder USA Network,Mr. Josh Cohen, Co-Founder, Managing Director, City Light Capita, Mr. Gregory C. Simon, Chief Executive Officer Poliwogg,Mr. Brian Trelstad, Managing Director, Bridges Ventures,Ms. Liesel Pritzker Simmons, Social entrepreneur, co-founder,Mr. Peter Samuelson, Chairman, Co-Founder and President, The Starlight Children’s Foundation,Ms. Kay Koplovitz, Co-founder Springboard Enterprises and Founder USA Network,Mr. Josh Cohen, Co-Founder, Managing Director, City Light Capita, Mr. Gregory C. Simon, Chief Executive Officer Poliwogg,Mr. Brian Trelstad, Managing Director, Bridges Ventures,Ms. Liesel Pritzker Simmons, Social entrepreneur, co-founder,Mr. Peter Samuelson, Chairman, Co-Founder and President, The Starlight Children’s Foundation,Ms. Kay Koplovitz, Co-founder Springboard Enterprises and Founder USA Network,Mr. Josh Cohen, Co-Founder, Managing Director, City Light Capita, Mr. Gregory C. Simon, Chief Executive Officer Poliwogg,Mr. Brian Trelstad, Managing Director, Bridges Ventures,Ms. Liesel Pritzker Simmons, Social entrepreneur, co-founder,

Mr. Peter Samuelson, Chairman, Co-Founder and President, The Starlight Children’s Foundation, Ms. Kay Koplovitz, Co-founder Springboard Enterprises and Founder USA Network, Mr. Josh Cohen, Co-Founder, Managing Director, City Light Capita, Mr. Gregory C. Simon, Chief Executive Officer Poliwogg, Mr. Brian Trelstad, Managing Director, Bridges Ventures, Ms. Liesel Pritzker Simmons, Social entrepreneur, co-founder,
 Blue Haven Initiative.

Keynote Speaker: Professor the Lord Darzi of Denham

Keynote Speaker: Professor the Lord Darzi of Denham

 Mr. Gary Fowlie, Head, ITU Liaison Office to the UN

 Mr. Gary Fowlie, Head, ITU Liaison Office to the UN
Dr Fiona Adshead, Director of Wellbeing and Public Health, Bupa

Zecki Dossal, Irene Pritzer, Tas Dossal

Zecki Dossal, Irene Pritzer, Tas Dossal

Gerard Mc Keon, Saralyn Mark

Gerard Mc Keon, Saralyn Mark

 Peter Samuelson,Founder, The Starlight Children’s Foundation,ana marina lebada

 Peter Samuelson,Founder, The Starlight Children’s Foundation
Ana Marina Lebada

Stephen Sahaya, Amelia Quelas

Stephen Sahaya, Amelia Quelas

Greg Simon, Katherine Kirsch, Gregory Casagrande

Greg Simon, Katherine Kirsch, Gregory Casagrande

Keynote Speaker: Mehmood Khan M.D. Executive Vice President and Chief Scientific Officer, Global Research & Development at PepsiCo.


Keynote Speaker: Mehmood Khan M.D. Executive Vice President and Chief Scientific Officer, Global Research & Development at PepsiCo.
Amir Dossal, Chairman,
 
Global Partnerships Forum

 

Agenda

Monday, May 5th:
 Global Health Impact Forum and Gala Dinner, United Nations General Assembly Hall

Welcoming Remarks

Mr. Amir Dossal, Chairman, Global Partnerships Forum

Mr. Thomas Gass,
Assistant Secretary-General for Policy Coordination and Inter-Agency Affairs, UN DESA

Dr. Roland Rich, Executive Director, United Nations Office for Partnerships

!
Opening Keynotes

Ambassador Gyan Chandra Acharya, High Representative for the Least Developed Countries, Landlocked Developing Countries and Small Island Developing States

His Excellency Dr Hamadoun Touré, Secretary-General of the International Telecommunication Union

Saralyn Mark, MD, a world renowned leader in women’s health, is an endocrinologist, geriatrician and women’s health specialist. She was the first Senior Medical Advisor to the Office on Women’s Health within the Department of Health and Human Services


 
 
Panel II: Britain’s best kept secret; opportunities to accelerate innovation with the National Health Service (NHS)

Chaired by Professor Freddie Hamdy, Head of the Nuffield Department of Surgery, Nuffield Professor of Surgery, Professor of
Urology and Honorary Consultant Urological Surgeon at the Oxford Radcliffe Hospitals and Fellow of Balliol College. He has spent
the past 10 years as founding Chair of Urology and was Director of the Division of Clinical Sciences, then Head of Oncology at the
University of Sheffield.

Lord Darzi of Denham, Chairman of Departments of Surgery at Imperial College London Professor Darzi holds the Paul Hamlyn
Chair of Surgery at Imperial College London, the Royal Marsden Hospital and the Institute of Cancer Research. He is Director of the
Institute of Global Health Innovation at Imperial College London and an Honorary Consultant Surgeon at Imperial College Hospital
NHS Trust.

Mr. Miles Ayling, Director of Innovation, NHS England & Chair of the NHS Innovation Challenge Prizes Expert Panel. Whilst
working for the Department of Health and NHS England, Director of Innovation, Mr. Ayling has been responsible for a number of
significant healthcare reform programs including the introduction of legislation on care trusts, delivery of commissioning a patient
led NHS and the reconfiguration of services in Primary Care Trusts.

Ms. Kate Bingham, Ms. Kate Bingham, Managing Partner, SV Life Sciences, London. The SVLS team manages five private
venture capital funds with approximately $1.9 billion of capital under management. The firm employs a diversified strategy within
life sciences in order to selectively capitalize on an expanding opportunity in biotech, medical devices and health-care services.
Sir Andrew Cash, Chief Executive, Sheffield Trust, founding Chair of the Foundation Trust Network (FTN) and previously served as
Director General, Department of Health, England and co-chair of the Department of Health/Ministry of Defence Partnership Board.
He is a visiting Professor in Leadership and Development at the Universities of Sheffield and York.

Sir Jonathan Michael, Chief Executive Oxford University Hospitals NHS Trust and Trustee of the King's Fund. His previous roles
include Managing Director of BT Health, Chief Executive of Guys and St Thomas’s Hospitals NHS Foundation Trust and Chief
Executive of University Hospitals Birmingham NHS Trust.
 
Luncheon:  United Nations Delegates Dining Room


Keynote Speaker: Professor the Lord Darzi of Denham, Professor Darzi holds the Paul Hamlyn Chair of Surgery at
Imperial College London, the Royal Marsden Hospital and the Institute of Cancer Research. He is Director of the Institute
of Global Health Innovation at Imperial College London and an Honorary Consultant Surgeon at Imperial College Hospital
NHS Trust. He was knighted for his services in medicine and surgery in 2002. In 2007, he was introduced to the United
Kingdom’s House of Lords as Professor the Lord Darzi of Denham and appointed Parliamentary Under-Secretary of State
at the Department of Health. Professor Darzi served as the United Kingdom’s Global Ambassador for Health and Life
Sciences. In 2013 he hosted the World Innovation Summit for Health in Doha, Qatar, under the Patronage of Her
Highness Sheikha Moza bint Nasser al Missned and Qatar Foundation.

!
Groundbreaking discoveries and innovations from Great Britain:
Mr. William Allan, CEO Vascular Flow Technologies
Mr. Ian Paling, CEO CellCoTec
 
 
Panel III:  How to identify innovations with the potential for transformational impact on disease outcomes and
ensure successful integration into medical practice: Respected leaders from the world of private-equity and highly
accomplished entrepreneurs will share secrets to identifying innovations with the potential for transformational impact and
making sure they get integrated into medical practice

Mr. Alexander Saint-Amand, President and CEO of GLG, the world’s largest membership for professional learning and expertise.
He is a founding member of the company and previously served as its Chief Operating Officer. During his tenure and under his
leadership, GLG has grown from a small start-up to one of New York City’s most successful venture-backed companies, having
facilitated over 1.5 million teaching and learning projects, and now with over 20 offices in 12 countries

Mr. Aly Sheezar Jeddy, Partner, HealthCare & Institutional Coverage, The Abraaj Group. Mr. Jeddy plays Group-wide investment
and firm management roles as well as supporting the firm’s investor relations activities in the United States. Mr Jeddy joined
Abraaj after twenty years at McKinsey & Company where he was a Senior Partner based in New York and Head of the Private
Equity and Principal Investing Practice in the Americas

Mr. Steve McLean, Arsenal Capital Partners; a progressive private equity firm with $1.65 billion under management that
facilitates transformational growth and change through a collaborative approach. Prior to joining Arsenal in 2010, Mr.
McLean was a Managing Director at Courtagen Capital Group and its predecessor companies where he invested in
healthcare companies

Mr. Adair Newhall, Principal, Domain Associates; Domain was one of the first venture capital firms to exclusively invest in
the life sciences sector. Domain has been involved in the formation of more than 250 companies, with more than $2.7
billion in capital raised to-date

Mr. Stanton (Stan) J. Rowe, Chief Scientific Officer & Corporate Vice President, Edwards Lifesciences and also serves as
Corporate Vice President, Advanced Technology. He joined the company in 2004 when Edwards acquired Percutaneous
Valve Technology, of which he was president and CEO and helped to found in 1999. Previously, Rowe was Corporate Vice
President of Business Development and Strategic Planning for Datascope and was Vice President of Business
Development for Johnson & Johnson’s Interventional Systems Division (JJIS), responsible for the company’s coronary
stent development efforts

Andrew Schiff, M.D., Managing Director, Aisling Capital a leading investment firm focused on novel approaches toward
the diagnosis, prevention, and treatment of life-threatening illnesses. Prior to joining Aisling, Dr. Schiff practiced internal
medicine at The New York Presbyterian Hospital where he maintains his position as a Clinical Assistant Professor of
Medicine
 
Groundbreaking discoveries and innovations: Recent discoveries in Neurodegenerative Diseases revealed; potential for
transformational impact on disease prevention, diagnosis and treatment; Chairman, Dr. Jonathan Sackier

Dr. RJ Tesi, CEO FPRT Bio

Dr. Alan Snow, Chairman and CEO ProteoTech

Mr. Larry Tiffany, CEO DioGenix
4:45 PM
Groundbreaking discoveries and innovations: Recent discoveries in Cancer revealed; potential for transformational impact on
disease prevention, diagnosis and treatment; Chairman, Dr. Jonathan Sackier
Dr. Graham Kelly, CEO Novogen

Mr. David Kalergis, CEO Diffusion
5:15 PM Mr. Tony Kuhn, CEO The Load Zero Foundation; Viral Load Testing for the Developing World
5:30PM
Panel IV: “Be He@lthy, Be Mobile”
Chaired by Mr. Gary Fowlie, Head, ITU Liaison Office to the UN. Global health policy leaders and internationally respected mobile
technology and broadband innovators will provide insights to the transformational impact of telemedicine, mobile health and
broadband on health access and outcome

Jacob Kumaresan, Head of WHO NYC office

Dr Fiona Adshead, Director of Wellbeing and Public Health, Bupa

Leslie Martinkovics*, Director, International Public Policy & Regulatory Affairs, Verizon Communications, Inc.

Erik Augustson, Program Director, National Cancer Institute, Tobacco Control Research Branch, Behavioral Research Program
6:30 PM
Gala Dinner:  United Nations Delegates Dining Room

Special performance by Mr. John Oates, 2014 Rock and Roll Hall of Fame Inductee

!
Keynote Speaker: Mehmood Khan M.D. Executive Vice President and Chief Scientific Officer, Global Research & Development at
PepsiCo. As chief scientific officer, Mehmood leads company-wide research and development (R&D); recruits highly regarded
clinical scientists, global health leaders and medical experts; launches research projects with leading universities; and opens
advanced R&D facilities. Prior to joining PepsiCo, Mehmood was as a faculty member at the Mayo Clinic and Mayo Medical
School in Rochester, Minn., serving as director of the Diabetes, Endocrine and Nutritional Trials Unit in the endocrinology division.
He also spent nine years leading programs in diabetes, endocrinology, metabolism and nutrition for the Hennepin County Medical
Center in Minneapolis
 
Tuesday, May 6th: Global Health Impact Forum and Tribute Reception, United Nations ECOSOC Chamber
Welcoming Remarks
Mr. Gary Fowlie, Head, ITU Liaison Office to the UN

Opening Keynote
Scott Parazynski, Astronaut, Everest Climber, Physician, and Telemedicine Champion

Mr. John H. Friedman, Founding and Managing Partner, Easton Capital, a leading private equity firm focused only on
those opportunities that offer services or products that can materially improve the healthcare people receive or reduce its
cost
10:30 AM
Panel I: The transformational impact of telemedicine, broadband and mobile health on health access and
outcomes; Global health policy leaders and internationally respected mobile technology and broadband innovators will
provide insights to the transformational impact of telemedicine, mobile health and broadband on health access and
outcomes
!
Mr. Yasuhiro Oishi, President, Kyocera Communications Inc.

Dr. Muzibul Khan, Corporate and Technology Planning, Kyocera Communications, Inc.

Steve Shaya M.D. of family office owned J&B Medical and member of ’Pietas’, the global nonprofit dedicated to
providing telemedicine solutions for rural and indigenous communities
11:00 AM
Groundbreaking discoveries and innovations: Recent discoveries in Nutrition revealed: Mr. Ethan Brown, CEO & Founder,
Beyond Meat: “Would we continue to raise and eat animals in such staggering numbers if we could make the same thing from
plants?” Insights revealing the importance and momentum of plant-based protein. Founded in 2009 by Ethan Brown and Brent
Taylor, Beyond Meat is supported by pro-social investors that share a passion and drive for changing the way the world gets its
protein, and include, among others, Bill Gates, Twitter co-founders Biz Stone and Evan Williams; investment firms Kleiner-Perkins
Caufield & Beyers, Morgan Creek Capital and Closed Look Capital; Seth Goldman, the founder of Honest Tea and the Humane
Society of the United States.
 
Panel II: How to win the battle against diabetes and obesity: Accomplished scientists, philanthropists, health policy experts
and senior executives from innovative private-sector companies will reveal specific initiatives that are helping to win the battle
against diabetes and obesity and explore opportunities to bring about lasting change

Chaired by Mr. David Jones, Jr. Director of Humana, The Humana Foundation, Inc., Board member of the National Committee on
U.S.-China Relations and Chairman of Chrysalis Ventures. Mr. Jones is a well-respected voice in healthcare business, innovation
and education. Mr. Jones brings a strong and well-rounded background in business, law and banking to his work at Chrysalis
Ventures, which he founded in 1993. David is active in civic and charitable affairs on both national and local levels

Mehmood Khan, M.D. Executive Vice President and Chief Scientific Officer, Global Research & Development at PepsiCo As chief
scientific officer, Mehmood leads company-wide research and development (R&D); recruits highly regarded clinical scientists,
global health leaders and medical experts; launches research projects with leading universities; and opens advanced R&D facilities

Mr. Paul LaViolette, Managing Partner SV Life Sciences and previously Chief Operating Officer at Boston Scientific Corporation
(BSC), also served at BSC as COO, Group President, President-Cardiology and President-International. During his 15 years at
BSC, he served as COO, Group President, President-Cardiology and President-International. Mr. LaViolette previously held
marketing and general management positions at CR Bard, and various marketing roles at Kendall (Covidien)

Saralyn Mark, M.D. Saralyn Mark, MD, a world renowned leader in women’s health, is an endocrinologist, geriatrician and
women’s health specialist. She was the first Senior Medical Advisor to the Office on Women’s Health within the Department of
Health and Human Services

Dr. Nandan Padukone, Ph.D., MBA, Vice President Office of Commercialization & Ventures, (OCV) Joslin Diabetes Institute of
Harvard Medical School. Dr. Padukone helped launch the OCV as a business center of Joslin Diabetes Center to create strategic
relationships with industry and leverage Joslin’s world-leading expertise in diabetes-directed research and clinical care

Maj. Gen. Gale Pollock, Former Deputy Surgeon General of the United Sates Army, and served as Acting Surgeon General of the
Army as well as the 22nd Chief of the Army Nurse Corps.  The Acting Surgeon General position made Maj. General Pollock one of
the few women in the US to run a Fortune 50 sized organization with a $9.7B budget

Dr. Robert E. Ratner is Chief Scientific & Medical Officer for the American Diabetes Association, the nation’s largest voluntary health
organization leading the fight to Stop Diabetes®. Dr. Ratner provides leadership and oversight of scientific and medical activities
including research, clinical affairs, program recognition and certification, medical information and professional education
 
Groundbreaking discoveries and innovations panel discussions: Recent discoveries in Infectious Diseases revealed;
potential impact on disease prevention, diagnosis and treatment; Chairman, Dr. Jonathan Sackier
Dr. Michel Bazinet, M.D. CEO Replicor
Mr. John Reisky de Dubnic, CEO Cavidi

Mr. Michael Smith, CFO Safe Eggs

Dr. Mark Benedyk, CEO Telephus Medical

Mr. Clifford Stocks, CEO Theraclone Sciences
6:30 PM
Tribute Reception: United Nations Delegate Dining Room

!
Special performance by Jihae; New York City-based singer/composer/multimedia artist
 
Groundbreaking discoveries and innovations panel discussions: Recent discoveries in Infectious Diseases revealed;
potential impact on disease prevention, diagnosis and treatment; Chairman, Dr. Jonathan Sackier
Dr. Michel Bazinet, M.D. CEO Replicor
Mr. John Reisky de Dubnic, CEO Cavidi

Mr. Michael Smith, CFO Safe Eggs

Dr. Mark Benedyk, CEO Telephus Medical

Mr. Clifford Stocks, CEO Theraclone Sciences
6:30 PM
Tribute Reception: United Nations Delegate Dining Room

!
Special performance by Jihae; New York City-based singer/composer/multimedia artist
 
Wednesday, May 7th: Global Health Impact Forum and Reception, Rockefeller University, Caspary Auditorium
Registration – Rockefeller University, Caspary Auditorium,

Coffee and Refreshments

8:45 AM
Welcoming Remarks
Mr. Zac Russell, Trustee, The Russell Family Foundation

Mr. Paul Reverdy and Ms. Christine Odabashian, Robotic Exoskeleton, Princeton University

Dr Murali Prahalad, PH. D., CEO Epic Sciences
Panel I: Ground-breaking approaches to discovery that are transforming innovation and outcomes: Case-studies reveal the
methods that are making a difference

The National Institutes of Health Oxford-Cambridge Scholars Program is having an extraordinary impact on the
development of the next generation of scientists. The Panel will reveal the ground-breaking methods and impact of this unique
program.

The Angiogenesis Foundation is the world’s first nonprofit organization dedicated to conquering disease using a new
approach based on angiogenesis, the growth of new capillary blood vessels in the body. The Foundation has developed a
unique social enterprise model based on international collaborations with leading medical academic centers, biopharmaceutical
companies, and government agencies, including the National Institutes of Health, National Cancer Institute, and the Food and
Drug Administration

William W. Li M.D.; President, Medical Director, and Co-founder of the Angiogenesis Foundation; Will trained in the lab of Dr.
Judah Folkman, pioneer of the angiogenesis field, and has been actively engaged in angiogenesis research and clinical
development for 22 years

Vincent W. Li M.D., M.B.A.; COO, Scientific Director, and Co-founder of the Angiogenesis Foundation; physician, scientist,
social entrepreneur and innovator; honored as HHMI Research Fellow and Harvard Business School Social Enterprise Fellow

Michael Lenardo M.D.; Co-founder of the National Institutes of Health Oxford-Cambridge Scholars Program; Section Chief at
Laboratory of Immunology, NIAID, NIH

Richard Siegel MD PhD, Co-founder of the National Institutes of Health Oxford-Cambridge Scholars Program; Clinical Director
of the National Institutes of Arthritis And Musculoskeletal Diseases

Ms. Arianne Richard, an NIH-Cambridge Scholar
10:00 AM
Mr. David Auerbach, CEO Sanergy: In the slums of Nairobi, millions of inhabitants rely on makeshift sanitation facilities. The
World Health Organization estimates that 2.6 billion people worldwide lack access to hygienic toilets, causing the spread of
disease. David Auerbach thinks the private sector can help.
 
Wednesday, May 7th: Global Health Impact Forum and Reception, Rockefeller University, Caspary Auditorium
Panel II: New York Academy of Sciences hosted panel, “Innovative Models of Funding for High Risk Disease”
Chaired by Mr. Ellis Rubinstein, President and Chief Executive Officer, The New York Academy of Sciences. The New York Academy
of Sciences CEO, Ellis Rubinstein, and a world class panel of accomplished experts will provide insights into how to leverage
investments in high risk areas of disease research such as neurodegenerative diseases and specifically Alzheimer’s. While research in
disease prevention, treatment and drug development can be high risk, under the right circumstances, philanthropists will support such
work. We have been honored to organize a panel addressing the newest thinking in social investment for high risk research

Mr. Labeeb Abboud, Senior Vice President Business Development and Strategy & General Counsel, IAVI; Fund Manager, Global
Health. Mr. Abboud is responsible for the legal, intellectual property and risk-management considerations associated with IAVI’s
operations and partnerships. He also oversees the organization’s business development efforts. Prior to joining IAVI, Mr. Abboud
served as general counsel to Atriax, a London-based electronic marketplace for foreign exchange products and as group counsel to
American Express Bank, Ltd. Mr. Abboud is currently vice chair of the Rainforest Alliance, a director of Shackleton Schools and
NEPCon and a member of the Council on Foreign Relations

Dr. Andrew Lo, PhD, Charles E. and Susan T. Harris Professor of Finance; Director, Laboratory for Financial Engineering, MIT Sloan
School of Management. Prior to MIT Sloan, he taught at the University of Pennsylvania Wharton School as the W.P. Carey Assistant
Professor of Finance from 1984 to 1987, and as the W.P. Carey Associate Professor of Finance from 1987 to 1988. A former governor
of the Boston Stock Exchange, he is currently a Research Associate of the National Bureau of Economic Research; a member of the
OFR Financial Research Advisory Committee, the New York Federal Reserve Board’s Financial Advisory Roundtable, and FINRA’s
Economic Advisory Committee

Mr. Pablo Legorreta, Founder and Chief Executive Officer, Royalty Pharma. Mr. Legorreta founded Royalty Pharma in 1996, after
creating and managing two “proof of principle” investment vehicles in 1993 and 1994 that invested in royalty interests in two leading
biotechnology products. Prior to founding these investment vehicles, Mr. Legorreta spent ten years at Lazard Frères where he
provided cross-border merger and acquisition and corporate finance advisory services to US and European corporations

Dr. Sam Hall, PhD, Associate, Apple Tree Partners. Dr. Hall has over a decade of experience in the life sciences across roles as a
private equity investor, investment banker and basic scientist. Prior to joining Apple Tree in 2013, he was a researcher at the University
of Cambridge in the UK, where his work focused on novel therapeutic strategies for autoimmune diseases. Previously Dr. Hall was a
member of the investment team at Symphony Capital, a private equity firm dedicated to investments in biopharmaceutical
development

Ms. Melissa Stevens, Deputy Executive Director, FasterCures a nonprofit think tank and center of the Milken Institute that works
across sectors to improve the effectiveness and efficiency of the medical research enterprise, and accelerate the discovery and
development of new treatments for deadly and debilitating diseases. Ms. Stevens manages planning and implementation of
FasterCures programs and directs the organization’s medical philanthropy efforts including the Philanthropy Advisory Service
 

Wednesday, May 7th: Global Health Impact Forum and Reception, Rockefeller University, Caspary Auditorium
Program Summary
0 AM
Groundbreaking discoveries and innovations panel discussions: Recent discoveries in Neurodegenerative Diseases revealed;
potential impact on disease prevention, diagnosis and treatment; Chairman, Dr. Jonathan Sackier
Mr. Stephen L. Hurst, CEO Savant HWP

Mr. Gerald Commisiong, CEO Amarantus BioScience
Ms. Marie Wesselhoft, CEO MSDx

Professor Malcolm Horne, Managing Director Global Kinetics
12:45 PM
!
Luncheon: Rockefeller University

2:00 PM
Groundbreaking discoveries and innovations panel discussions: Recent discoveries in Enabling Platform Technologies
revealed; potential impact on disease prevention, diagnosis and treatment; Chairman, Mr. Alex Charlton
Dr. Trevor Castor, CEO Aphious

Dr. Steven Tregay, Forma Therapeutics

Mr. Richard T. Schumacher, CEO Pressure BioScience
2:50 PM
Groundbreaking discoveries and innovations panel discussions: Recent discoveries in Cancer revealed; potential impact on
disease prevention, diagnosis and treatment; Chairman, Mr. Alex Charlton
Mr. George Colberg, M.D. CEO Kalos Therapeutics

Dr. George Thomas, PhD. CEO Marsala Biotech
 
Wednesday, May 7th: Global Health Impact Forum and Reception, Rockefeller University, Caspary Auditorium

Groundbreaking discoveries and innovations panel discussions: Recent discoveries in Molecular Diagnostics revealed;
potential impact on disease prevention, diagnosis and treatment; Chairman, Dr. Jonathan Sackier
Mr. David Weaver, CEO Blaze Medical Devices

Dr. Eytan R. Barnea, MD FACOG, S.I.E.P. Chairman The Society for the Investigation of Early Pregnancy
4:00 PM
Groundbreaking discoveries and innovations panel discussions: Recent Discoveries in Infectious Diseases revealed; potential
impact on disease prevention, diagnosis and treatment; Chairman, Dr. Jonathan Sackier
Dr. David Huizenga, CEO Klaren Technologies

Mr. Kenneth Kelley, CEO PaxVax

Dr. Brett Baker, CEO Microbion Corporation
6:30 PM
Cavendish Awards Reception: Rockefeller University, Benjamin and Irma G. Weiss Building

Family Office Panel: "What makes a grant great or philanthropic gift? Family office insight to grant and philanthropy requests that
family offices and their foundations want to fund.  Family offices will reveal their favorite grants and philanthropic gifts, what made
them great and provide insights into what makes a grant application compelling.”

Chaired by Mr. Gregory C. Simon, Chief Executive Officer Poliwogg; Mr. Simon has held senior positions in both houses of
Congress and the White House and led FasterCures/The Center for Accelerating Medical Solutions, the national patient advocacy
nonprofit

Mr. Jesse H. Ausubel, Director of the Program for the Human Environment of The Rockefeller University

Ms. Kedge Martin, Co-founder of Longbow, Ms. Martin a founder member of TRH Duke and Duchess of Cambridge and Prince
Harry’s Charities Forum, and formerly CEO of Sentebale, Prince Harry’s charity for African orphans

Ms. Ghislaine Maxwell, Founder The TerraMar Project

Ms. Irene Pritzker, President, IDP Foundation, dedicated to developing programs in education that are sustainable and move away
from aid dependent model

Steve Shaya, M.D., Dr. Shaya’s family founded and own J&B Medical, he is als

 

joyce brooks, gerard mckeon.  photo by:  rose billings

To list an Upcoming Event
Contact: joyce@blacktiemagazine.com

Save the Date
Celebrity Philanthropy News
Society News

Black Tie Magazine TV

Promote Your Event or Business
Contact: gerard@blacktiemagazine.com

Event Resource Directory,   Promote your Services
Event Talent  Directory,  
Feature your Talent
Co-hosting events with Black Tie
Advertising

 

Back To Society News


 


 




 

 
 
Avazoo

Launch of the First
Billion Dollar Charity Raffle.


Featured Events

 
Kentuckey Derby
 

Selfless Love Foundation

 

Featured Real Estate

 

Maplemiint Farm

 

Family Film Awards

 

Family Film Awards

 

Featured Foundations

 
chuck feeney
 
peoples money
 
international peace day
 
Gavi
 
american portrait
 
greenpeace
 
ItC for Peace
 
THE JOHN F. KENNEDY PROFILE IN COURAGE AWARD®
 
Médecins Sans Frontières
 
Nigeria Solidarity Support Fund
 
the people's vaccine
 
global citizen
 

vall to unite

 

Search the Site

 

 

Impact Investment

 
carbon geocycle
 

Black Tie China

 
ma.xiaoqiu, Dyf Entertainment
 
lang lang foundation
 

Black Tie Philippines

 
black tie philippines
 

Nightlife with Rose Billings

 
sara Johnson
 
debutante Ball
 
Judy Kuriansky
 
Gerard Mc Keon
 

Celebrity Philanthropy News
 

st_patricks_day_2020
 
sera Vergera
 
nicole Kidnman, jennifer Aniston
 
jean shafiroff, paul mc cartney
 
princess margaret of kent
 
hudson river park annual Gala
 
Al Pacino, American Icon Awards
 
clive davis
 
proincess grace awards
 
american hospital of paris foundation
 
french heritage society
 
lupus research alliance
 
un women for peace
 
ben kingsley
 
ceylon tea party
 
ecosoc
 
joyce brooks
 
central park conservatory
 
UN Correspondents Association
 
cardinal dolan
 
palm beach heart ball
 
vienese opera ball
 
lady in red gala
 
sanford stem cell
 
weizmann institute
 
carlos slim
 
israel 65th anniversary
 

Black Tie International Realty

 
secret paradise resort
 
round island, seychelles
 
 
 

Event Resources Directory

event resource directory
 
 


 

 
 
 
 
 
 
 
 
 
 
 

Copyright 2006 Black Tie Magazine. All Rights Reserved .

Privacy Policy |